Zostavax
STN: 125123
Proper Name: Zoster Vaccine, Live
Tradename: Zostavax
Manufacturer: Merck & Co., Inc
Indication:
- For prevention of herpes zoster (shingles) in individuals 50 years of age and older.
Product Information
- Package Insert - Zostavax (Frozen)
- Package Insert - Zostavax (Refrigerator Stable)
- Patient Information - Zostavax (Frozen)
- Patient Information - Zostavax (Refrigerator Stable)
Supporting Documents
- February 21, 2019 Approval Letter - Zostavax
- January 23, 2019 Approval Letter - Zostavax
- April 18, 2018 Summary Basis for Regulatory Action - Zostavax
- April 19, 2018 Approval Letter - Zostavax
- March 21, 2018 Approval Letter - Zostavax
- August 3, 2017 Summary Basis for Regulatory Action - ZOSTAVAX
- August 3, 2017 Approval Letter - ZOSTAVAX
- March 15, 2017 Summary Basis for Regulatory Action - ZOSTAVAX
- March 15, 2017 Approval Letter - Zostavax
- February 17, 2016 Approval Letter - ZOSTAVAX
- Supporting Documents older than three years - ZOSTAVAX